CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Redeemable Noncontrolling Interest	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Treasury stock	Retained Earnings
Beginning balance at Apr. 30, 2022	$ 913.8		$ 19.2	$ 169.0	$ (26.8)	$ (11.5)	$ 763.9
Beginning balance (in shares) at Apr. 30, 2022			38,276,968
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(0.4)						(0.4)
Issuance of restricted stock, net of tax withholding (in shares)			54,479
Purchases of common stock	$ (31.6)		$ (0.5)				(31.1)
Purchases of common stock (in shares)	(825,814)		(825,814)
Stock-based compensation expense	$ 5.7			5.7
Other comprehensive loss	(27.5)				(27.5)
Net Income (Loss)	49.1						49.1
Dividends on common stock	(10.3)						(10.3)
Ending balance at Oct. 29, 2022	898.8		$ 18.7	174.7	(54.3)	(11.5)	771.2
Ending balance (in shares) at Oct. 29, 2022			37,505,633
Beginning balance at Jul. 30, 2022	911.4		$ 19.0	172.0	(36.2)	(11.5)	768.1
Beginning balance (in shares) at Jul. 30, 2022			38,001,714
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding (in shares)			12,098
Purchases of common stock	$ (19.7)		$ (0.3)				(19.4)
Purchases of common stock (in shares)	(508,179)		(508,179)
Stock-based compensation expense	$ 2.7			2.7
Other comprehensive loss	(18.1)				(18.1)
Net Income (Loss)	27.6						27.6
Dividends on common stock	(5.1)						(5.1)
Ending balance at Oct. 29, 2022	898.8		$ 18.7	174.7	(54.3)	(11.5)	771.2
Ending balance (in shares) at Oct. 29, 2022			37,505,633
Beginning balance at Apr. 29, 2023	941.8		$ 18.6	181.0	(19.0)	(11.5)	772.7
Beginning Balance at Apr. 29, 2023		$ 11.1
Beginning balance (in shares) at Apr. 29, 2023			37,167,375
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(3.8)		$ 0.1	(0.1)			(3.8)
Issuance of restricted stock, net of tax withholding (in shares)			189,454
Purchase of redeemable noncontrolling interest		(11.1)
Purchases of common stock	$ (7.8)		$ (0.2)				(7.6)
Purchases of common stock (in shares)	(322,779)		(322,779)
Stock-based compensation expense	$ 2.9			2.9
Other comprehensive loss	(23.9)				(23.9)
Net Income (Loss)	(54.4)						(54.4)
Dividends on common stock	(9.9)						(9.9)
Ending balance at Oct. 28, 2023	844.9		$ 18.5	183.8	(42.9)	(11.5)	697.0
Ending balance (in shares) at Oct. 28, 2023			37,034,050
Beginning balance at Jul. 29, 2023	931.4		$ 18.7	182.5	(23.1)	(11.5)	764.8
Beginning Balance at Jul. 29, 2023		0.9
Beginning balance (in shares) at Jul. 29, 2023			37,356,156
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding (in shares)			673
Purchase of redeemable noncontrolling interest		$ (0.9)
Purchases of common stock	$ (7.8)		$ (0.2)				(7.6)
Purchases of common stock (in shares)	(322,779)		(322,779)
Stock-based compensation expense	$ 1.3			1.3
Other comprehensive loss	(19.8)				(19.8)
Net Income (Loss)	(55.3)						(55.3)
Dividends on common stock	(4.9)						(4.9)
Ending balance at Oct. 28, 2023	$ 844.9		$ 18.5	$ 183.8	$ (42.9)	$ (11.5)	$ 697.0
Ending balance (in shares) at Oct. 28, 2023			37,034,050